Security key
03969K108
Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)
CUSIP: 03969K108
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 46,348,278
- Total 13F value
- $961,255,152
- Share change
- +33,258
- Put/Call ratio
- 22%
- SEC-reported price per share
- $20.74
- Number of holders
- 89
- Value change
- -$1,852,441
- Number of buys
- 47
- Number of sells
- 40
- Shares outstanding
- 125,896,702
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
89
Top holders
10
ARQT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Ownership snapshot
Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRAZIER MANAGEMENT LLC
Disclosed value leader
FRAZIER MANAGEMENT LLC
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F
Highest disclosed value: $201,494,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FRAZIER MANAGEMENT LLC has the largest disclosed position value at $201.49M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRAZIER MANAGEMENT LLC's linked filing trail.
Disclosed position value
Top 5
FRAZIER MANAGEMENT LLC
$201.49M
FMR LLC
$180.04M
ORBIMED ADVISORS LLC
$145.1M
BlackRock Finance, Inc.
$100.24M
Bain Capital Life Sciences Invest...
$95.06M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRAZIER MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$201,494,000
8,434,232 shares
|
— | 30 Sep 2021 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$180,041,000
7,536,265 shares
|
— | 30 Sep 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$145,104,000
6,073,850 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$100,241,000
4,195,926 shares
|
— | 30 Sep 2021 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
—
denominator unverified
|
$95,065,000
3,979,292 shares
|
— | 30 Sep 2021 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$47,591,000
1,992,107 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
89
Shares
46,348,278
Rows available
89
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
103
Q4 2021 holders
89
Holder diff
-14
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend